Syria Lags in Surrendering Deadliest Chemical Arms

Syrian rebel fighters fire a machine gun during a Tuesday clash with government forces in Aleppo. Syria's regime has given up 29.5 percent of its deadliest warfare substances and a significantly larger portion of lower-grade materials, the Organization for the Prohibition of Chemical Weapons said on Wednesday.
National Journal
Diane Barnes
March 19, 2014, 10:45 a.m.

Syr­ia’s re­gime re­cently handed over more of its chem­ic­al arms, but it has been slow to give up its dead­li­est sub­stances, newly re­leased fig­ures in­dic­ate.

Syr­i­an Pres­id­ent Bashar As­sad’s gov­ern­ment on Fri­day and Monday placed sep­ar­ate batches of war­fare chem­ic­als on for­eign freight­ers docked at the port of Latakia, ac­cord­ing to fresh data cir­cu­lated by the Or­gan­iz­a­tion for the Pro­hib­i­tion of Chem­ic­al Weapons. The watch­dog agency is over­see­ing a glob­al ef­fort to re­move and des­troy the full Syr­i­an ar­sen­al by the end of June.

The re­gime’s ninth and tenth chem­ic­al ship­ments were partly com­posed of “Pri­or­ity 1” agents, which in­ter­na­tion­al au­thor­it­ies have said rep­res­ent the most dan­ger­ous com­pon­ent of As­sad’s chem­ic­al stock­pile.

Dam­as­cus has giv­en up a far great­er pro­por­tion of its ma­ter­i­als deemed less dan­ger­ous, though. It has shipped out more than four-fifths of its lower-grade chem­ic­al war­fare stocks, but only 29.5 per­cent of the Pri­or­ity 1 stocks, ac­cord­ing to the OP­CW state­ment.

In total, As­sad’s gov­ern­ment has re­lin­quished “more than 45 per­cent” of its de­clared stock­pile, the in­ter­na­tion­al watch­dog agency said in an e-mail. The gov­ern­ment agreed to hand over its chem­ic­al weapons last Septem­ber, weeks after a sar­in nerve agent re­lease al­legedly killed more than 1,400 people in an op­pos­i­tion-held sub­urb of the Syr­i­an cap­it­al.

Syr­ia’s gov­ern­ment cur­rently is ex­pec­ted to fin­ish ship­ping out its chem­ic­al arms by the middle of April. The 41-na­tion OP­CW Ex­ec­ut­ive Coun­cil ori­gin­ally de­man­ded that Dam­as­cus fin­ish hand­ing over its Pri­or­ity 1 stocks by the end of last year, and its re­main­ing ma­ter­i­als by early Feb­ru­ary.

What We're Following See More »
SEVEN-POINT LEAD IN A FOUR-WAY
Quinnipiac Has Clinton Over 50%
2 hours ago
THE LATEST

Hillary Clinton leads Donald Trump 51%-41% in a new Quinnipiac poll released today. Her lead shrinks to seven points when the third-party candidates are included. In that scenario, she leads 45%-38%, with Gary Johnson pulling 10% and Jill Stein at 4%.

Source:
PROCEDURES NOT FOLLOWED
Trump Not on Ballot in Minnesota
4 hours ago
THE LATEST
MIGHT STILL ACCEPT FOREIGN AND CORPORATE MONEY
Chelsea to Stay on Board of Clinton Foundation
4 hours ago
THE LATEST

Is the Clinton family backtracking on some of its promises to insulate the White House from the Clinton Foundation? Opposition researchers will certainly try to portray it that way. A foundation spokesman said yesterday that Chelsea Clinton will stay on its board, and that the "foundation’s largest project, the Clinton Health Access Initiative, might continue to accept foreign government and corporate funding."

Source:
INTERCEPT IN MIDDLE EAST
Navy Calls Iranian Ships’ Actions Dangerous, Unprofessional
5 hours ago
THE LATEST

"Four Iranian ships made reckless maneuvers close to a U.S. warship this week, the Pentagon said Thursday, in an incident that officials said could have led to dangerous escalation." The four Iranian vessels engaged in a "high-speed intercept" of a U.S. destroyer in the Strait of Hormuz. A Navy spokesman said the Iranina actions "created a dangerous, harassing situation that could have led to further escalation including additional defensive measures" by the destroyer.

Source:
$300 SAVINGS CARD
Under Pressure, EpiPen Maker Drops Prices
5 hours ago
THE LATEST

Amid public outcry and the threat of investigation by the Senate Judiciary Committee, Mylan has agreed to effectively drop the price of EpiPens. "The company, which did not lower the drug's list price, said it would reduce the patient cost of EpiPen through the use of a savings card, which will cover up to $300 of EpiPen 2-Pak."

Source:
×